• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    CHF Solutions Appoints CEO

    Freehand Partners with Imperial Medial Solutions

    Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant

    Hillrom to Buy Bardy Diagnostics for $375M

    Global Tissue and Organ Transplantation Market to Surpass $25.6 Billion by 2027
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    Medbio LLC

    K-Tube Technologies

    Qosina Corp.

    maxon
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    maxon

    Concise Engineering

    Medicoil

    Spectrum Plastics Group

    FUTEK Advanced Sensor Technology Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Heart of the Matter: Trends in Cardiology

    Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.

    Related CONTENT
    • Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation
    • CMS Expedites Breakthrough Device Access; Industry Applauds
    • Unique Contact Lens Sensor System & Manufacturing Process Developed
    • Medtech Matters: Talking Robotic Surgery with Zimmer Biomet
    • CES News: Philips Highlights Healthcare at Home
    Maria Shepherd, President and Founder, Medi-Vantage11.04.20
    When the first reports were issued about paclitaxel, many were concerned about paclitaxel coated stents and possible increased mortality in patients treated with paclitaxel-coated stents/balloons for peripheral artery disease.1 The authors of a JACC article cite multiple meta-analyses as do those who argue against the use of paclitaxel coated devices, but the real question is, what impact does this have on interventional cardiology devices?

    In 1993, the FDA approved the first coronary intervention stent in the U.S., Cook Medical’s Gianturco-Roubin Flex Stent bare-metal stent (BMS). Approval of the Flex-Stent came one year after a review by FDA’s circulatory system devices panel.2

    Cook launched its coronary stent with great fanfare using company-sponsored training sessions beginning in July 1993 and priced it at $1,150.2 Interventional cardiologists (IC) were enthusiastic about the potential for the stent technology to treat coronary artery disease and lined up for training to treat their patients. The stent was also marketed in Korea, Australia, and Singapore.

    With such an enormous lead, how did Cook lose first-mover advantage in a market that would grow to more than $7 billion in global sales? The coronary stent market is forecasted to grow from $7.16 billion in 2016 and reach $10.3 billion by 2021 (Table 1) with an astonishing CAGR of 7.6 percent in a market almost 30 years old.3


    Table 1: Global stent market growth3

    Why Is It Important?
    At the time, before the market direction was clear, game changing product design decisions like “Which drug coating do we use on our first DES?” are incredibly tough calls to make—significant dollars and market position are at risk.

    It began with the introduction of higher cost drug-eluting stents (DES) that caused a significant shift in the revenues of the stent market. DES were first sold in the U.S. in 2002, a daring strategic move with higher business risk to cardiovascular device companies, but it also offered the upside of delivering the holy grail—a lower restenosis rate. Choosing the drug to use to coat the BMS was a complex decision for companies. Many pharmaceutical compounds were evaluated, including Taxol (paclitaxel), which was also used as an anti-cancer medication. It was argued paclitaxel was a risk to patient safety because the dosage range over which paclitaxel is used in stenting is close to the drug’s toxicity level.4

    Cordis (then a division of Johnson & Johnson; now part of Cardinal Health) chose Sirolimus in its DES and began an exclusive licensing agreement with Wyeth Pharmaceuticals. Cordis chose Sirolimus because it could inhibit cellular growth linked to restenosis, could be formulated into a polymer matrix, and was highly stable. Sirolimus is effective over a wide range of concentrations and, in evaluations, was non-toxic at high concentrations. The Cordis Cypher was the first mover in the DES market.

    By 2003, the Cypher penetrated the BMS market by more than 60 percent. Cordis had many competitors—Boston Scientific, Guidant, and Medtronic—all working on DES offerings. In 2004, Boston Scientific was awarded FDA approval for its Taxus DES.

    Newcomers to this competitive market know clinical data is a must have, and industry relationships are hard to displace. Almost all ICs take charge in the interventional suite and medical device representatives have their work cut out for them to be subtly central to the procedure to generate and maintain influence, while bringing service to the IC that cultivates loyalty to the products, the sales person, and the company.5 Medtech representatives and some doctors think a sales rep brings many benefits to the hospital, by amplifying productivity and offsetting deficits of procedure room staff.

    Where Is This Growth Coming From?
    Of the three major segments of coronary stents—BMS, DES, and bioabsorbable stents—bioabsorbable stents are expected to have the highest growth between now and 2022,6 although they represent the smallest revenue segment of the group. The worldwide bioabsorbable stent market is forecast to reach $417 million by 2022, up from $242 million in 2017 (Table 2)—a CAGR of 11.5 percent.6 Market drivers of bioresorbable stents are the growing aging population, rising percutaneous coronary intervention procedures, and increasing demand created by medical device manufacturers’ clinical trials of bioresorbable stents. There are highly regarded clinical benefits attributed to bioresorbable stents, such as a decrease in thrombosis and inflammation complications.7 One market obstacle was the high cost of bioabsorbable coronary stents when the Absorb stent from Abbott was introduced in 2016.


    Table 2: Global bioabsorbable stent market revenue forecast6

    Shifting the ASP Up, Up, Up
    It doesn’t happen very often, but when introduced, the innovation and promise of bioabsorbable coronary stents caused an ASP shift in the upwards direction. ASP data is difficult to obtain and a 2019 article about the sales of coronary stents in India provide insights to global pricing and the power of enormous market demand in a country with a population of more than 1.4 billion people.

    In February 2017, the government of India regulated the selling price of coronary stents. According to an interventional cardiologist in India, stent prices dropped by an average of 80 percent.8

    Before the price was regulated, the cost to the patient of the only approved bioresorbable stent in India was 200,000 Indian Rupees (INR; approximately $2,800), compared to DES costs that ranged from INR 85,000 to 160,000 ($1,190 to $2,240). Allegations were made that hospitals and ICs obtained kickbacks for implanting stents.8

    The Indian government cut and regulated stent prices significantly (Table 3). The cost for patients for a bioabsorbable stent was stabilized to INR 60,000 (approximately $840). BMS and DES were capped at INR 7,500 and 30,000, respectively ($105 and $420).8 The government reportedly used industry-supplied data while Indian physicians voiced concerns about how low profitability would drive away large stent manufacturers from supplying the newest technologies. The medical device industry pushed back, stating that supplying cardiology products at a loss would cause them to lose money, obviously to put pressure on the government. In early 2017, Abbott announced it would withdraw two stents from the Indian market after the government’s move to cap stent prices.9 The Abbott bioresorbable stent disappeared from shelves.


    Table 3: Changes to stent prices in India (2017)8

    The Medi-Vantage Perspective
    By 2020, DES continued to dominate the overall coronary stent market and had the highest revenue market share forecasted until the end of 2024, estimated at nearly 95 percent of the total market.10 Good marketing and an intimate knowledge of pricing strategy was central to managing this enormous global market. Make price strategy a key part of your marketing and product development so the market you manage gets all the investment in development it warrants at your medical device company. 

    References
    1. bit.ly/mpo201101
    2. bit.ly/mpo201102
    3. bit.ly/mpo201103
    4. bit.ly/mpo201104
    5. bit.ly/mpo201105
    6. bit.ly/mpo201106
    7. bit.ly/mpo201107
    8. bit.ly/mpo201108
    9. bit.ly/mpo201109
    10. bit.ly/mpo201110


    Maria Shepherd has more than 20 years of leadership experience in medical device/life-science marketing in small startups and top-tier companies. After her industry career, including her role as VP of marketing for Oridion Medical where she boosted the company valuation prior to its acquisition by Medtronic, and director of marketing for Philips Medical, she founded Medi-Vantage. Medi-Vantage provides marketing and business strategy and innovation research for the medical device industry. Shepherd has taught marketing and product development courses, speaks regularly at medtech conferences, and can be reached at mshepherd@medi-vantage. Visit her website at www.medi-vantage.com.
    Related Searches
    • Cardiovascular
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Medtech Matters: Medtronic Medtech Matters: Medtronic's Robotic Surgery Status
    Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation
    CMS Expedites Breakthrough Device Access; Industry Applauds CMS Expedites Breakthrough Device Access; Industry Applauds
    Unique Contact Lens Sensor System & Manufacturing Process Developed Unique Contact Lens Sensor System & Manufacturing Process Developed
    Medtech Matters: Talking Robotic Surgery with Zimmer Biomet Medtech Matters: Talking Robotic Surgery with Zimmer Biomet
    CES News: Philips Highlights Healthcare at Home CES News: Philips Highlights Healthcare at Home
    Olympus and Hitachi Sign Five-Year Contract Olympus and Hitachi Sign Five-Year Contract
    Acutus Medical Launches AcQCross Transseptal System in Europe Acutus Medical Launches AcQCross Transseptal System in Europe
    Study Shows Lungpacer System Improves Diaphragm Strength by More Than 300 Percent Study Shows Lungpacer System Improves Diaphragm Strength by More Than 300 Percent
    Solvay Partners With PrinterPrezz on 3D Printing for Medical Devices Solvay Partners With PrinterPrezz on 3D Printing for Medical Devices
    New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System
    Quantitative Transmission Ultrasound Outperforms Mammography Quantitative Transmission Ultrasound Outperforms Mammography
    BioSerenity Achieves FDA Clearance for Wearable Device System BioSerenity Achieves FDA Clearance for Wearable Device System
    Greenlight Guru and Nelson Labs Partner Greenlight Guru and Nelson Labs Partner
    Olympus Releases ScopeLocker Endoscope Storage Cabinet Olympus Releases ScopeLocker Endoscope Storage Cabinet

    Related Columns

    • Cardiovascular
      The TAVR Plot Thickens

      The TAVR Plot Thickens

      Transcatheter aortic valve replacement (TAVR) surgery has typically targeted patients considered too risky to undergo open-heart surgery.
      Sam Brusco, Associate Editor 09.06.19

    • Cardiovascular | Diagnostics | Digital Health | Patient Monitoring
      Cardiac Care on the Can

      Cardiac Care on the Can

      ...
      Sam Brusco, Associate Editor 04.03.19

    • Cardiovascular
      What’s New with TAVR?

      What’s New with TAVR?

      ...
      Maria Shepherd, President and Founder, Medi-Vantage 04.03.19


    • Cardiovascular
      15 Years of Consi-stent Medtech Progress

      15 Years of Consi-stent Medtech Progress

      ...
      Sam Brusco, Associate Editor 06.04.18

    • Cardiovascular | Digital Health | Neurological
      The Human Cyborg, Circa 2033

      The Human Cyborg, Circa 2033

      ...
      Michael Barbella, Managing Editor 06.04.18

    • Cardiovascular | Digital Health
      Feeding the Medtech Innovation Pipeline

      Feeding the Medtech Innovation Pipeline

      ...
      Maria Shepherd, President and Founder, Medi-Vantage 01.30.18


    • Cardiovascular | Surgical
      Age of Innovation for Valves

      Age of Innovation for Valves

      ...
      David Novotny, Novella Clinical 09.01.17

    • Cardiovascular | Diagnostics
      Changing Administrations and the Strategy for Value-Based Growth in Medtech

      Changing Administrations and the Strategy for Value-Based Growth in Medtech

      ...
      Maria Shepherd, Medi-Vantage 07.26.17

    • Cardiovascular | Diagnostics | Digital Health | Neurological | Patient Monitoring | Surgical
      Four Common Misperceptions of Accelerated FDA Approval

      Four Common Misperceptions of Accelerated FDA Approval

      ...
      Matthew M. Lowe, Executive Vice President, MasterControl 03.07.17


    • Cardiovascular | Diagnostics | Neurological | Patient Monitoring | R&D & Design | Surgical | Testing
      First in Man

      First in Man

      ...
      Steve Maylish, Chief Commercial Officer, Fusion Biotec 03.07.17

    • Cardiovascular | Contract Manufacturing | Materials | R&D & Design
      Critical Aspects for Medical Textile Implant Manufacturing

      Critical Aspects for Medical Textile Implant Manufacturing

      ...
      Rick Crane, Vice President of Innovation Services Group, J-Pac Medical 10.12.16

    • Cardiovascular | Contract Manufacturing | Materials | Testing
      Sterilization Innovations Lead to New Guidance Document

      Sterilization Innovations Lead to New Guidance Document

      ...
      James A. Dunning, QPC Services 05.06.16


    • Cardiovascular
      The Tortuous Trek Toward True Transparency

      The Tortuous Trek Toward True Transparency

      ...
      Michael Barbella , Managing Editor 03.10.16

    • Cardiovascular

      Greatbatch-Lake Region Medical Merger Complete

      ...
      11.11.15

    • Cardiovascular | Contract Manufacturing | Materials | Molding

      Medtech Supplier Consolidation, the Boeing Way

      ...
      Michael Barbella, Managing Editor 11.11.15


    Trending
    • Philips Buys Capsule Technologies In $635M Deal
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Top 10 Trends In The Medical Device And Equipment Industry
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    Breaking News
    • CHF Solutions Appoints CEO
    • Freehand Partners with Imperial Medial Solutions
    • Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant
    • Hillrom to Buy Bardy Diagnostics for $375M
    • Global Tissue and Organ Transplantation Market to Surpass $25.6 Billion by 2027
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise
    Qualitas Health/iwi Raises $10 Million in Investment Round
    Aker BioMarine Expands Krill Portfolio with Novel Protein Hydrolysate
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CHF Solutions Appoints CEO
    Freehand Partners with Imperial Medial Solutions
    Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
    NovaQuest Private Equity Acquires CoreRx
    JS Bio and Etta Biotech Advancing Partnership
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Marino Belotti Presents New Website
    Essence Cosmetics Expands in the U.S.
    Sigma Beauty Launches 'Brush Care' Sets at Sephora
    Happi

    Latest Breaking News From Happi

    Mix:Bar Launches at Target
    Crystal Deodorant Unveils Magnesium-Enriched Sticks
    Euromonitor Reveals Top 10 Global Consumer Trends for 2021
    Ink World

    Latest Breaking News From Ink World

    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Packaging Printing Market Worth $433.4 Billion by 2025: MarketsandMarkets
    O-I Foundation Gifts $50k to Facilitate COVID-19 Vaccine Access
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Honeywell Delivered 225 Million Masks in December
    Techtextil, Texprocess Postponed to 2022
    Super Strong Inks Survive Tough Environments
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Appoints SVP of Operations
    DePuy Synthes Receives 510(k) FDA Clearance for VELYS Robotic-Assisted Solution
    OrthoPediatrics Expands Agent Network in Three European Countries
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login